Literature DB >> 19224153

Up-regulation of VLDL receptor expression and its signaling pathway induced by VLDL and beta-VLDL.

Zhiguo Liu1, He Li, Yinghong Li, Yan Wang, Yiqiang Zong, Youmei Feng, Zongchen Feng, Yaozu Deng, Shen Qu.   

Abstract

Very low density lipoprotein receptor (VLDLR) is thought to participate in the pathogenesis of atherosclerosis induced by VLDL and beta-VLDL. The present study was undertaken to elucidate the effects of VLDL and beta-VLDL on VLDLR expression and its signaling pathway. RAW264.7 cells were incubated with VLDL and beta-VLDL. The expression of VLDLR mRNA was detected by RT-PCR. The transcriptional activity of VLDLR gene was detected in recombinant plasmid pGL4.2VR-luciferase transfected RAW264.7. Western blot assay was used to detect the changes of phosphorylated ERK1/2 protein. Inhibitors or activators were used to observe the signal pathway involving VLDLR expression regulation. The results showed that VLDL and beta-VLDL stimulated ERK1/2 activity in a PKC-dependent manner. VLDL or beta-VLDL-induced VLDLR expression on macrophages was extremely abolished by inhibitors ERK1/2 or PKC. Our findings revealed that VLDL or beta-VLDL-induced VLDLR expression via PKC/ERK cascades and the effect was linked to the transcriptional activation of VLDLR gene promoter.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224153     DOI: 10.1007/s11596-009-0101-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  26 in total

1.  Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.

Authors:  Erin D MacDougall; Farah Kramer; Patti Polinsky; Shelley Barnhart; Bardia Askari; Fredrik Johansson; Rebecca Varon; Michael E Rosenfeld; Kazuhiro Oka; Lawrence Chan; Stephen M Schwartz; Karin E Bornfeldt
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

2.  Rapid isolation of large amount of plasma VLDL and LDL by a two step ultracentrifugation.

Authors:  C B Wang; Y M Feng; Y Q Zong; Y Z Deng; Z C Feng
Journal:  J Tongji Med Univ       Date:  1995

3.  Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs.

Authors:  Hiroko Shirotani-Ikejima; Koichi Kokame; Tsutomu Hamuro; Guojun Bu; Hisao Kato; Toshiyuki Miyata
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

4.  Regulation of ApoE receptor proteolysis by ligand binding.

Authors:  Hyang-Sook Hoe; G William Rebeck
Journal:  Brain Res Mol Brain Res       Date:  2005-03-23

5.  beta-Migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation.

Authors:  D Zhao; J Letterman; B M Schreiber
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

6.  Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia.

Authors:  K Nakazato; T Ishibashi; K Nagata; Y Seino; Y Wada; T Sakamoto; R Matsuoka; T Teramoto; M Sekimata; Y Homma; Y Maruyama
Journal:  Atherosclerosis       Date:  2001-04       Impact factor: 5.162

7.  Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages.

Authors:  S Kosaka; S Takahashi; K Masamura; H Kanehara; J Sakai; G Tohda; E Okada; K Oida; T Iwasaki; H Hattori; T Kodama; T Yamamoto; I Miyamori
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

8.  Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promoter.

Authors:  J L Wood; A F Russo
Journal:  J Biol Chem       Date:  2001-03-30       Impact factor: 5.157

9.  Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1.

Authors:  Hans H Bock; Yves Jossin; Petra May; Oliver Bergner; Joachim Herz
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

10.  Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.

Authors:  D J Webb; K S Thomas; S L Gonias
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  6 in total

1.  Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).

Authors:  Yewei Xing; William E Rainey; John W Apolzan; Omar L Francone; Ruth B S Harris; Wendy B Bollag
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

Review 2.  Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.

Authors:  Ying-Ying Tsai; William E Rainey; Wendy B Bollag
Journal:  J Endocrinol       Date:  2016-12-02       Impact factor: 4.286

3.  Enhancer deletion and allelic effects define a regulatory molecular mechanism at the VLDLR cholesterol GWAS locus.

Authors:  James P Davis; Swarooparani Vadlamudi; Tamara S Roman; Monica Zeynalzadeh; Apoorva K Iyengar; Karen L Mohlke
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

4.  VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.

Authors:  Ying-Ying Tsai; William E Rainey; Maribeth H Johnson; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2016-05-21       Impact factor: 4.102

5.  Unavailability of liver triacylglycerol increases serum cholesterol concentration induced by dietary cholesterol in exogenously hypercholesterolemic (ExHC) rats.

Authors:  Yasutake Tanaka; Koji Nagao; Hideaki Nakagiri; Toshirou Nagaso; Yasue Iwasa; Haruhiko Mori; Makoto Asahina; Katsumi Imaizumi; Masao Sato
Journal:  Lipids Health Dis       Date:  2014-01-22       Impact factor: 3.876

6.  Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population.

Authors:  Fan Zhao; Yue Qi; Jing Liu; Wei Wang; Wuxiang Xie; Jiayi Sun; Jun Liu; Yongchen Hao; Miao Wang; Yan Li; Dong Zhao
Journal:  EBioMedicine       Date:  2017-08-31       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.